Clinical Trial Update: Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dactinomycin or methotrexate for low-risk gestational trophoblastic neoplasia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choriocarcinoma
• Gestational Trophoblastic Neoplasia
• Hydatidiform Mole

Drugs mentioned

• Dactinomycin (dactinomycin)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: GOG Foundation | Conditions: Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor | Phase 3 | Status: COMPLETED | Results posted: 2019-08-13